Grassley Wants More Active FDA Oversight Of 510(k) Modification Decisions
This article was originally published in The Gray Sheet
Executive Summary
Sen. Chuck Grassley, R-Iowa, is questioning why FDA does not play a more active role in determining when a change to a device requires a new 510(k)